share_log

Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20

Benzinga ·  Dec 14, 2023 07:39

Wells Fargo analyst Mohit Bansal initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight rating and announces Price Target of $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment